Eversense CGM Wins a 2018 “Best of What’s New” Award
November 27 2018 - 4:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS) a medical
technology company focused on the development and commercialization
of a long-term, implantable continuous glucose monitoring (CGM)
system for people with diabetes, today has announced that the
Eversense® Continuous Glucose Monitoring (CGM) System has been
awarded one of Popular Science’s 2018 “Best of What’s New”
Awards in the Health category.
Each year, Popular Science magazine reviews thousands of new
products and innovations in order to choose the top 100 winners
across 10 categories. In order to win in a category, a product or
technology must represent a significant step forward in its
category.
“We are pleased and honored to be chosen by Popular Science as a
‘Best of What’s New’ winner for 2018,” said Tim Goodnow, President
and CEO of Senseonics. “Our goal is to create innovative technology
to help people with diabetes have an easier time managing their
disease. This recognition just reinforces how consumer-driven
medical devices can transform patients’ management of a chronic
disease. At Senseonics, we’re proud that we’re changing the
paradigm for diabetes care.”
The Eversense CGM System consists of a fluorescence-based
sensor, a smart transmitter worn over the sensor to facilitate data
communication, and a mobile app for displaying glucose values,
trends and alerts. In addition to featuring the first long-term and
first implantable CGM sensor, the system is also first to feature a
smart transmitter that provides wearers with discreet on-body
vibratory alerts for high and low glucose and that can be removed,
recharged and re-adhered without discarding the sensor. The sensor
can now be inserted subcutaneously in the upper arm by a health
care provider via a brief in-office procedure.
“The ‘Best of What's New’ Awards allow us the chance to examine
and honor the best innovations of the year,” says Popular Science
Editor-in-Chief Joe Brown. “This collection shapes our future,
helps us be more efficient, keeps us healthy and safe, and lets us
have some fun along the way. From simple household items to massive
space-exploration tools, we’re proud to bring you the Best of
What's New 2018.”
Patients who are interested in getting started on Eversense can
sign up at www.eversensediabetes.com/get-started-today. Physicians,
nurse practitioners or physician assistants interested in offering
the Eversense CGM System for their patients can contact 844-SENSE4U
(844-736-7348).
About Eversense
The Eversense® Continuous Glucose Monitoring (CGM) System is
indicated for continually measuring glucose levels in persons age
18 and older with diabetes for up to 90 days. It is intended to
complement, not replace, fingerstick blood glucose monitoring. The
sensor insertion and removal is performed by a health care
provider. The Eversense CGM System is a prescription device;
patients should talk to their health care provider to learn more.
For important safety information, see
https://eversensediabetes.com/safety-info/.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
About Best Of What’s New
Since 1988, the editors of Popular Science have reviewed
thousands of products in search of the top 100 tech innovations of
each year—breakthrough products and technologies that represent a
significant advancement in their categories. Best of What's New
awards are presented to 100 new products and technologies in 10
categories: Aerospace, Automotive, Engineering, Entertainment,
Gadgets, Health, Home, Recreation, Security, Software.
About Popular Science
As one of America’s oldest and most trusted magazines, Popular
Science has spent a century and a half bringing readers the most
amazing innovations and discoveries. From thought leaders to
skeptics, from digital natives to print devotees, Popular Science’s
audience is as diverse as the stories in and on our pages. And we
all have one thing in common: a boundless sense of wonder.
Established in 1872, Popular Science is published by Bonnier Corp.
Bonnier Corp. is one of the largest consumer publishing groups in
the United States, and is the leading media company serving
passionate, highly engaged audiences with more than 30 special
interest magazines and related multimedia projects and events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181127005724/en/
Investor Relations
Contact:InvestorRelations@senseonics.com
Media Contact:SignalWest Public RelationsJeff
Christensen, 831-566-0275jeff@signalwestpr.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Oct 2023 to Oct 2024